Dr Reddy's gets USFDA inspection closure report for Srikakulam manufacturing plant in Andhra Pradesh

New Delhi: Drug major Dr Reddy’s Laboratories on Friday said the US health regulator has closed inspection of its manufacturing facility in Srikakulam, Andhra Pradesh.

The US Food and Drug Administration (USFDA) had issued a warning letter to the facility in November, 2015, after inspecting it in 2014. Click here to follow LIVE news and updates on stock markets “We have received the establishment inspection report from the USFDA, for the Srikakulam facility, indicating closure of the audit and the inspection classification of this facility,” Dr Reddy’s Laboratories said in a regulatory filing. With this, all facilities under warning letter are now determined as ‘voluntary action indicated’, the drug major said.